FCX
61
3
UNP
60
8
EBAY
52
5
AN
61
3
STI
31
17
SYF
88
3
NVDA
52
-4
AKAM
53
2
IVZ
55
6
CLX
68
-3
AIZ
82
2
NEM
48
2
NKE
40
4
KMB
44
5
CSX
64
4
ADT
46
3
WBA
54
6
PLD
61
5
BF.B
37
4
UNH
63
4
FCX
61
3
UNP
60
8
EBAY
52
5
AN
61
3
STI
31
17
SYF
88
3
NVDA
52
-4
AKAM
53
2
IVZ
55
6
CLX
68
-3
AIZ
82
2
NEM
48
2
NKE
40
4
KMB
44
5
CSX
64
4
ADT
46
3
WBA
54
6
PLD
61
5
BF.B
37
4
UNH
63
4
Financhill
Back

AIM ImmunoTech Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

AIM
AIM ImmunoTech

Last Price:
0.23
Seasonality Move:
1.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

AIM ImmunoTech Price Quote

$0.23
+0.02 (+7.98%)
(Updated: November 26, 2024 at 5:55 PM ET)

AIM ImmunoTech Key Stats

Sell
31
AIM ImmunoTech (AIM) is a Sell
Day range:
$0.21 - $0.22
52-week range:
$0.16 - $0.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
58.54
P/B ratio:
4.66%
Volume:
269.1K
Avg. volume:
541.6K
1-year change:
-50.43%
Market cap:
$13.6M
Revenue:
$202K
EPS:
$-0.47

How Much Does AIM ImmunoTech Make?

Is AIM ImmunoTech Growing As A Company?

  • What Is AIM ImmunoTech's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.24%
  • What Is AIM ImmunoTech's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

AIM ImmunoTech Stock Price Performance

  • Did AIM ImmunoTech Stock Go Up Last Month?
    AIM ImmunoTech share price went down by -20.25% last month
  • Did AIM's Share Price Rise Over The Last Year?
    AIM share price fell by -50.43% over the past 1 year

What Is AIM ImmunoTech 52-Week High & Low?

AIM ImmunoTech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AIM ImmunoTech?

  • How Much Debt Does AIM ImmunoTech Have?
    Total long term debt quarterly is $2.7M
  • How Much Cash Does AIM ImmunoTech Have?
    Cash and short term investments quarterly total is $7.2M
  • What Is AIM ImmunoTech’s Book Value Per Share?
    Book value per share is 0.05

Is AIM ImmunoTech Cash Flow Positive?

  • What Is AIM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$20.7M
  • What Is AIM ImmunoTech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.6M
  • What Is AIM ImmunoTech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $788K

AIM ImmunoTech Return On Invested Capital

  • Is Management Doing A Good Job?
    AIM return on invested capital is -219.06%
  • What Is AIM ImmunoTech Return On Assets?
    ROA measures how assets are converting to revenues and is -129.02%
  • What Is AIM Return On Equity?
    ROE is a measure of profitability and is -256.33%

AIM ImmunoTech Earnings Date & Stock Price

AIM ImmunoTech Competitors

  • Who Are AIM ImmunoTech's Competitors?
    Below is a list of companies who compete with AIM ImmunoTech or are related in some way:
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Protalix BioTherapeutics Inc (PLX)
    • Xtant Medical Holdings Inc (XTNT)

AIM ImmunoTech Dividend Yield

AIM ImmunoTech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20.5%
Revenue: -23.91% 199.91%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.00
Upside from Last Price: 1308.45%

Major Shareholders

  • How many AIM shares are owned by institutional investors?
    11.2M AIM shares are owned by institutional investors
  • How many AIM shares are owned by insiders?
    5M AIM shares are owned by insiders